R&F Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

R&F Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$43K	Buy	+3,601	New	+$78.7K	0.01%	656

Other funds holding TNDM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

R&F Capital Advisors's TNDM Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q1 2017: 3,601 shares worth $43K. The stake represents 0.01% of the portfolio and ranks #656 among its holdings.

80 funds tracked by Wall St. Rank hold TNDM as of Q1 2017.

R&F Capital Advisors held 3,601 shares of Tandem Diabetes Care worth $43K as of Q1 2017.
Tandem Diabetes Care was a new R&F Capital Advisors position in Q1 2017.
Tandem Diabetes Care made up 0.01% of R&F Capital Advisors's portfolio in Q1 2017, its #656 holding.
80 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.